UBS raised the firm’s price target on Natera (NTRA) to $290 from $280 and keeps a Buy rating on the shares. UBS sees sustained growth momentum with some operating leverage, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTRA:
- Natera price target raised to $215 from $205 at Wells Fargo
- Natera price target raised to $257 from $239 at Baird
- Natera price target raised to $280 from $270 at Barclays
- Natera: Underpenetrated Growth, Emerging Catalysts, and a Clear Path to Cash Flow Support a Buy Rating
- Natera reports FY25 EPS ($1.52), consensus ($2.42)